2015-08-17T10:22:32-05:00 2014-09-30 263753134 CBIZ TOFIAS 500 BOYLSTON STREET BOSTON MA 02116 990 2013-10-01 364695829 JOSLIN TECHNOLOGIES LLC JOSL 6172265744 ONE JOSLIN PLACE BOSTON MA 02115 MARIA BUCKLEY CLERK 6172265744 2015-08-14 1 CRAIG KLEIN P00734640 6177610600 2015-08-11 2013 2016-03-07 17:11:31Z JOHN L BROOKS III ONE JOSLIN PLACE BOSTON MA 02115 302933 0 X WWW.JOSLIN.ORG X LLC 2011 MA JOSLIN TECHNOLOGIES, LLC ("THE ORGANIZATION") IS AN INTELLECTUAL PROPERTY ACCELERATOR. ITS SOLE FUNCTION IS TO TAKE SIGNIFICANT INTELLECTUAL PROPERTY OPPORTUNITIES AND DEVELOP THEM ON BEHALF OF ITS SOLE MEMBER, JOSLIN DIABETES CENTER, INC. ("JDC"). 3 0 0 0 0 0 0 10000 0 292933 0 0 48822 0 48822 302933 0 0 0 0 0 0 0 0 0 38517 1368457 38517 1368457 10305 -1065524 45361 53805 7608 1081576 37753 -1027771 JOSLIN TECHNOLOGIES, LLC ("THE ORGANIZATION") IS AN INTELLECTUAL PROPERTY ACCELERATOR. ITS SOLE FUNCTION IS TO TAKE SIGNIFICANT INTELLECTUAL PROPERTY OPPORTUNITIES AND DEVELOP THEM ON BEHALF OF ITS SOLE MEMBER, JOSLIN DIABETES CENTER, INC. ("JDC"). 0 0 1368457 292933 THE ORGANIZATION IS A COMPANY FOCUSED ON CREATING NOVEL PRODUCTS AND SERVICES IN DIABETES AND OBESITY MANAGEMENT TO ADDRESS THE GROWING NEED FOR BETTER DRUG TREATMENTS, DIAGNOSTICS AND CLINICAL CARE FOR PATIENTS.DIABETES IS RECOGNIZED AS A GROWING PANDEMIC WITH TWENTY-FIVE (25) MILLION PEOPLE IN THE UNITED STATES SUFFERING FROM THE DISEASE AND ABOUT THREE HUNDRED AND FIFTY (350) MILLION WORLDWIDE. THIS REPRESENTS A SIGNIFICANT MEDICAL RESEARCH MARKET FOR NEW DRUGS, DIAGNOSTIC DEVICES AND INFORMATION TECHNOLOGY APPROACHES FOR IMPROVED CARE AND PATIENT MANAGEMENT. 1368457 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 0 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MA X BETH CADLE 6173095749 ONE JOSLIN PLACE BOSTON MA 02215 JOHN L BROOKS III PRESIDENT/CEO 1.00 39.00 X X 0 681109 31479 GEORGE KING MD DIRECTOR 1.00 39.00 X 0 337842 36165 ROSS J MARKELLO CFO/TREASURER 1.00 39.00 X X 0 485212 42676 NANDAN PADUKONE DIRECTOR 1.00 39.00 X 0 194845 26407 TIMOTHY GARLAND TREASURER 1.00 39.00 X 0 164998 25715 MARIA BUCKLEY CLERK 1.00 39.00 X 0 271194 16126 0 2135200 178568 0 0 1 0 JOSLIN DIABETES CENTER INC ONE JOSLIN PLACE BOSTON MA 02115 MANAGEMENT SERVICES 1368457 1 10000 10000 CONTRACT REVENUE 900099 292933 292933 292933 302933 292933 0 0 X 1368457 1368457 1368457 1368457 0 0 40720 49184 4641 4621 45361 53805 4943 300000 7608 776633 7608 1081576 X 37753 -1027771 37753 -1027771 45361 53805 -1065524 0 X 0 1 X 1 0 X 10000 10000 87122 48822 292933 428877 87122 48822 302933 438877 0 82122 43822 262934 388878 82122 43822 262934 388878 49999 87122 48822 302933 438877 X 0 DUE TO JOSLIN DIABETES CENTER 776633 776633 X 302933 0 302933 0 302933 1368457 0 1368457 0 1368457 PART X, LINE 2: JOSLIN, THE CLINIC, AND JOSLIN TECHNOLOGIES HAVE BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE (IRS) AS ORGANIZATIONS DESCRIBED IN INTERNAL REVENUE CODE (THE "CODE") SECTION 501(C)(3) AND, THEREFORE, ARE EXEMPT FROM TAXATION ON RELATED INCOME UNDER SECTION 501(A) OF THE CODE. THE IRS HAS ALSO PREVIOUSLY DETERMINED THAT THESE ENTITIES ARE NOT PRIVATE FOUNDATIONS PURSUANT TO SECTION 509(A) OF THE CODE. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED IN THE ACCOMPANYING CONSOLIDATED FINANCIAL STATEMENTS. THE CENTER RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT OF BEING SUSTAINED. RECOGNIZED INCOME TAX POSITIONS ARE MEASURED AT THE LARGEST AMOUNT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED. CHANGES IN RECOGNITION IN MEASUREMENT ARE REFLECTED IN THE PERIOD IN WHICH THE CHANGE IN JUDGMENT OCCURS. THE CENTER DID NOT RECOGNIZE THE EFFECT OF ANY INCOME TAX POSITION IN EITHER 2014 OR 2013. 0 0 0 0 0 0 0 0 0 JOHN L BROOKS III PRESIDENT/CEO 0 679219 0 0 0 1890 0 3530 0 27949 0 712588 0 0 GEORGE KING MD DIRECTOR 0 335952 0 0 0 1890 0 19495 0 16670 0 374007 0 0 ROSS J MARKELLO CFO/TREASURER 0 483322 0 0 0 1890 0 19495 0 23181 0 527888 0 0 NANDAN PADUKONE DIRECTOR 0 193695 0 0 0 1150 0 5726 0 20681 0 221252 0 0 TIMOTHY GARLAND TREASURER 0 164488 0 0 0 510 0 11589 0 14126 0 190713 0 0 MARIA BUCKLEY CLERK 0 270444 0 0 0 750 0 0 0 16126 0 287320 0 0 PART I, LINE 3: JOSLIN TECHNOLOGIES' TOP MANAGEMENT OFFICIAL AND TOP FINANCIAL OFFICIAL ARE COMPENSATED THROUGH ITS RELATED ORGANIZATION, JOSLIN DIABETES CENTER. THE FOLLOWING IS THE DISCLOSURE AS PRESENTED ON THE JOSLIN DIABETES CENTER'S FORM 990 REGARDING COMPENSATION FOR THE TOP OFFICERS AND THE CEO: EXECUTIVE COMPENSATION INCLUDES THE CEO AND THE SENIOR LEADERSHIP TEAM. PAY FOR THE CEO IS DETERMINED BY THE BOARD. THE HUMAN RESOURCE DEPARTMENT PROVIDES SURVEY DATA AS REQUESTED. SENIOR LEADERSHIP TEAM PAY IS DETERMINED BY THE CEO WITH SURVEY DATA PROVIDED BY HR. EXECUTIVE COMPENSATION IS REVIEWED ANNUALLY BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ALL CASES, COMPENSATION IS DETERMINED BY INDEPENDENT PERSONS. INDIVIDUALS ARE PROHIBITED FROM ACTIVE PARTICIPATION IN ANY DECISIONS REGARDING THEIR OWN COMPENSATION. FORM 990, PART VI, SECTION A, LINE 3 PURSUANT TO A SERVICES AGREEMENT, JOSLIN DIABETES CENTER, INC. IS SUPERVISING, DIRECTING AND CONTROLLING THE DAY-TO-DAY BUSINESS ACTIVITIES, MANAGEMENT, ADMINISTRATION, AND OPERATION OF JOSLIN TECHNOLOGIES, LLC BUSINESS AND ASSETS. FORM 990, PART VI, SECTION A, LINE 6 JOSLIN TECHNOLOGIES, LLC HAS ONE MEMBER, JOSLIN DIABETES CENTER, INC. ("THE CENTER"). FORM 990, PART VI, SECTION A, LINE 7A JOSLIN TECHNOLOGIES, LLC HAS ONE MEMBER, JOSLIN DIABETES CENTER, INC. ("THE CENTER"), WITH THE POWER TO APPOINT AND REMOVE MEMBERS OF THE GOVERNING BODY. FORM 990, PART VI, SECTION B, LINE 11 THE FORM 990 IS REVIEWED BY MEMBERS OF THE FISCAL SERVICES DEPARTMENT FOR COMPLETENESS AND ACCURACY. A COPY OF THE FORM AS IT WILL BE FILED WITH THE INTERNAL REVENUE SERVICE WILL BE E-MAILED TO THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE GENERAL COUNSEL'S OFFICE DISTRIBUTES AN ANNUAL DISCLOSURE FORM TO ALL OFFICERS, TRUSTEES AND EMPLOYEES ANNUALLY. THE INFORMATION DISCLOSED IS REVIEWED BY THE GENERAL COUNSEL AND, IF A POTENTIAL CONFLICT EXISTS, BY THE COMMITTEE AS DEFINED BELOW. THE DISCLOSURE FORMS OF THE VICE PRESIDENTS WILL BE REVIEWED BY THE GENERAL COUNSEL AND THE PRESIDENT, THE DISCLOSURE FORM OF THE PRESIDENT WILL BE BE REVIEWED BY THE GENERAL COUNSEL AND THE CHAIR OF THE BOARD. IF A POTENTIAL CONFLICT IS FOUND TO EXIST, THE INDIVIDUAL SHALL REFRAIN FROM ACTIVE PARTICIPATION IN ANY DECISION CONCERNING THE MATTER. FORM 990, PART VI, SECTION C, LINE 19 THE FORM 990 AND THE AUDITED FINANCIAL STATEMENTS ARE AVAILABLE FOR REVIEW AT THE FISCAL SERVICES OFFICE AND THE MASSACHUSETTS ATTORNEY GENERAL'S WEBSITE. THEY ARE ALSO AVAILABLE IN AN ELECTRONIC FORMAT UPON REQUEST. THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND THE WHISTLEBLOWER POLICY ARE AVAILABLE FOR REVIEW AT THE OFFICE OF THE GENERAL COUNSEL OR IN AN ELECTRONIC FORMAT UPON REQUEST. FORM 990, PART VI, SECTION B, LINE 15A & 15B: JOSLIN TECHNOLOGIES, LLC DOES NOT DIRECTLY COMPENSATE ITS CEO OR ANY OF ITS OTHER OFFICERS. COMPENSATION FOR THESE INDIVIDUALS IS SET BY THE JOSLIN DIABETES CENTER ("THE CENTER") FOLLOWING THE PROCEDURES OF THE CENTER AS OUTLINED BELOW: EXECUTIVE COMPENSATION INCLUDES THE CEO AND THE SENIOR LEADERSHIP TEAM. PAY FOR THE CEO IS DETERMINED BY THE BOARD. THE HUMAN RESOURCE DEPARTMENT PROVIDES SURVEY DATA AS REQUESTED. SENIOR LEADERSHIP TEAM PAY IS DETERMINED BY THE CEO WITH SURVEY DATA PROVIDED BY HR. EXECUTIVE COMPENSATION IS REVIEWED ANNUALLY BY THE COMPENSATION COMMITTEE OF THE BOARD. IN ALL CASES, COMPENSATION IS DETERMINED BY INDEPENDENT PERSONS. INDIVIDUALS ARE PROHIBITED FROM ACTIVE PARTICIPATION IN ANY DECISIONS REGARDING THEIR OWN COMPENSATION. FORM 990, PART VI, SECTION B: EXISTENCE OF POLICIES THE CONFLICT OF INTEREST POLICY, WHISTLEBLOWER POLICY AND DOCUMENT RETENTION POLICY FOR THE JOSLIN DIABETES CENTER ARE IN EFFECT FOR, AND GOVERN, JOSLIN TECHNOLOGIES. REGULAR AND CONSISTENT MONITORING AND ENFORCEMENT OF COMPLIANCE WITH THESE POLICIES ARE MANAGED BY THE JOSLIN DIABETES CENTER. FORM 990, PART IX, LINE 11G SERVICE AGREEMENTS: PROGRAM SERVICE EXPENSES 1,368,457. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,368,457. JOSLIN DIABETES CENTER INC ONE JOSLIN PLACE BOSTON MA 022155306 042203836 DIABETES RESEARCH FACILITY MA 501(C)(3) LINE 7 N/A 0 JOSLIN CLINIC INC ONE JOSLIN PLACE BOSTON MA 022155306 222984590 DIABETES CLINIC MA 501(C)(3) LINE 11A, I N/A 1 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0